Breakthrough T1D (formerly JDRF)- Innovative Awards & Postdoctoral Fellowships (RMS360 platform)
Breakthrough T1D — rolling/semi-annual cycles
Offers Innovative Awards up to $200,000 for one year for high-risk, high-reward research, and three-year Postdoctoral Fellowships for early-career scientists entering the T1D field. Atom
Breakthrough T1D — rolling/semi-annual cycles
Offers Innovative Awards up to $200,000 for one year for high-risk, high-reward research, and three-year Postdoctoral Fellowships for early-career scientists entering the T1D field. Atom
NIDDK Digital Health Technology for Type 2 Diabetes Management (RFA-DK-26-315)
NIH/NIDDK — Deadline: October 6, 2026
Supports research on multimodal digital health technology for remote management of type 2 diabetes. This funding opportunity invites applications examining the efficacy and clinical effectiveness of multimodality digital health technology approaches to remote diabetes management. Grants
NIH/NIDDK — Deadline: October 6, 2026
Supports research on multimodal digital health technology for remote management of type 2 diabetes. This funding opportunity invites applications examining the efficacy and clinical effectiveness of multimodality digital health technology approaches to remote diabetes management. Grants
Breakthrough T1D (formerly JDRF- Kellogg Family Early-Career Patient-Oriented T1D Research Award
Breakthrough T1D — Deadline: July 2, 2026 (next cycle likely similar timing in 2027)
Supports early-career clinical investigators pursuing patient-oriented type 1 diabetes research, with $1,000,000 available over a five-year project period for clinicians within five years of their first faculty appointment. Keck School of Medicine of USC
Breakthrough T1D — Deadline: July 2, 2026 (next cycle likely similar timing in 2027)
Supports early-career clinical investigators pursuing patient-oriented type 1 diabetes research, with $1,000,000 available over a five-year project period for clinicians within five years of their first faculty appointment. Keck School of Medicine of USC
American Diabetes Association - ADA Postdoctoral Fellowships
ADA Postdoctoral Fellowships
ADA — Deadline: April 30, 2026 (next cycle expected similar timing)
Provides up to three years of funding support including salary stipend, fringe benefit costs, and a training allowance for each award year. Pedsresearch
ADA Postdoctoral Fellowships
ADA — Deadline: April 30, 2026 (next cycle expected similar timing)
Provides up to three years of funding support including salary stipend, fringe benefit costs, and a training allowance for each award year. Pedsresearch
American Diabetes Association Pathway to Stop Diabetes — Initiator & Accelerator Awards
ADA — Deadline: May 19, 2026 (next cycle expected similar timing)
The Initiator Award supports the transition of scientists from mentored training to independent research faculty, with Phase 1 providing up to two years of support at $100,000 per year. The Accelerator Award targets early-career investigators establishing independent research programs. Diabetes Professionals
ADA — Deadline: May 19, 2026 (next cycle expected similar timing)
The Initiator Award supports the transition of scientists from mentored training to independent research faculty, with Phase 1 providing up to two years of support at $100,000 per year. The Accelerator Award targets early-career investigators establishing independent research programs. Diabetes Professionals
New LLHF Start-Up Grant Opportunity – For Early-Career Diabetes & Aging Investigators
Sponsor: Larry L. Hillblom Foundation (LLHF) – Start-Up Grant
Focus areas: Diabetes or Aging (broadly defined)
Eligible institutions: PI’s lab must be based at a California institution
Award: Up to $120,000/year for up to 3 years (non-renewable; includes up to 10% indirects)
Full details and online application are here: https://llhf.org/programs/startup-grant/
Sponsor: Larry L. Hillblom Foundation (LLHF) – Start-Up Grant
Focus areas: Diabetes or Aging (broadly defined)
Eligible institutions: PI’s lab must be based at a California institution
Award: Up to $120,000/year for up to 3 years (non-renewable; includes up to 10% indirects)
Key features:
Designed to support highly promising early-stage investigators starting independent labs
Preference for applicants who have held a faculty position (ordinarily Assistant Professor) for ≤1 year; not eligible if in a faculty role >3 years before the application date
Strong institutional commitment required: full start-up package, office/admin support, research space, access to core facilities, and teaching/clinical load limited to ≤1 day/week
Effort expectations: 80% research effort in Year 1; in Years 2–3, 80% research effort overall with at least 20% effort and salary from the Hillblom Start-Up Grant
Timeline:
Application portal opens: January 1, 2026
Application deadline: January 31, 2026, 5:00 pm PST
Funding decisions: June 2026
Anticipated start date: July 2026
Full details and online application are here: https://llhf.org/programs/startup-grant/
2024 Application for eWEAR Health Prize @ Stanford U.
The eWEAR Health Prize @ Stanford U. is a pitch competition with the winning contestant receiving a $50,000 prize. The focus of the competition is Deep Tech at the intersection of the medical/health sector with engineering hardware, materials, robotics, artificial intelligence, blockchain, space technology and other interdisciplinary science and engineering. The pitch competition will be an in-person event on November 8, 2024 on the campus of Stanford University.
The eWEAR Health Prize @ Stanford U. is a pitch competition with the winning contestant receiving a $50,000 prize. The focus of the competition is Deep Tech at the intersection of the medical/health sector with engineering hardware, materials, robotics, artificial intelligence, blockchain, space technology and other interdisciplinary science and engineering. The pitch competition will be an in-person event on November 8, 2024 on the campus of Stanford University.
Request for Applications to advance collaborative research in T1D prevention
Requests for applications are now open for new collaborations with the Environmental Determinants of Islet Autoimmunity (ENDIA) Study Group and leading experts around the world to answer important unknowns about disease mechanisms with the long-term aim of preventing type 1 diabetes (T1D).
Requests for applications are now open for new collaborations with the Environmental Determinants of Islet Autoimmunity (ENDIA) Study Group and leading experts around the world to answer important unknowns about disease mechanisms with the long-term aim of preventing type 1 diabetes (T1D).
Advancing the Understanding of Type 1 Diabetes Pathogenesis (Biosamples Provided from a Primary Prevention Trial)
Launched in late 2017, the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) is designed to carry out newborn screening in the general population, identify infants at high genetic risk of developing type 1 diabetes, and offer them participation in trials to prevent disease initiation.
Launched in late 2017, the Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) is designed to carry out newborn screening in the general population, identify infants at high genetic risk of developing type 1 diabetes, and offer them participation in trials to prevent disease initiation.
Breakthrough T1D Request for Applications: Collaborative Advancement of Cures for T1D
The goal of this funding opportunity is to accelerate the development of therapies to prevent, slow, halt or reverse the progression of Type 1 Diabetes (T1D) and/or cure established T1D through the advancement of high-impact research carried out by coordinated, multidisciplinary teams.
The goal of this funding opportunity is to accelerate the development of therapies to prevent, slow, halt or reverse the progression of Type 1 Diabetes (T1D) and/or cure established T1D through the advancement of high-impact research carried out by coordinated, multidisciplinary teams.